Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Current research explores hair growth drugs, while future research aims for personalized treatments.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Spironolactone may help reduce hair loss in androgenic alopecia.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Nutricosmetics with active ingredients can help with hair loss and improve hair growth.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Toxoplasma gondii infection may increase testosterone levels in males.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Acupressure improves quality of life in PCOS patients.

Estrogens and progesterone are key in regulating melasma pigmentation.